GoodRX, Weight Watchers and LifeMD all said they will offer Novo Nordisk's new weight-loss pill, Wegovy, on their respective platforms.
U.S. regulators approved the new pill last month. At that time, Novo Nordisk said it planned to start selling the pill in the U.S. in early January, with a cash price of $149 a month for the starting dose.
Drug companies and analysts have said the pills will tap in to demand from people who don't want an injection or would prefer the cadence of a daily dose. Pills also offer the prospect of lower prices and better health-insurance coverage than injections, because pills cost less to make, The Wall Street Journal previously reported.
GoodRX, Weight Watchers and LifeMD all expanded their partnerships with Novo Nordisk to offer the new weight-loss pill through their respective platforms, a push to further expand access to popular GLP-1 treatments.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.